Brickell Biotech Inc reports results for the quarter ended in June - Earnings Summary

Fresh Tracks Therapeutics

11/08/2022 22:54

* Brickell Biotech Inc  BBI.OQ  reported a quarterly
adjusted loss
of 1 cent​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss of
$1.44 per share.
    * Revenue rose 2,757.6% to $4.32 million from a year ago;
analysts
expected $3.14 million. 
    * Brickell Biotech Inc's reported EPS for the quarter was a
loss
of 1 cent​.
    * The mean earnings estimate of analysts had risen by
about 36.1%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Brickell Biotech Inc shares had fallen by 35.4% this
quarter and
lost 64.5% so far this year.
    * The company reported a quarterly loss of $1.15 million.
    * Wall Street's median 12-month price target for Brickell
Biotech
Inc is $45.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:53 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -1.44          -0.01          Beat
 Mar. 31 2022      -2.59          -3.60          Missed
 Dec. 31 2021      -3.82          -2.70          Beat
 Sep. 30 2021      -5.62          -7.20          Missed